Vaccinex raises ~$3.7M in private placement of common stock and warrants

VACCINEX, INC.

Issues 3.84M shares and warrants for 3.84M shares at $0.725 per unit; also 1.27M pre-funded warrants at $0.7249.
Common warrants exercisable at $1.00/share; pre-funded warrants at $0.0001; both immediately exercisable.
Investors include company chair Albert Friedberg (FCMI) and CEO Maurice Zauderer (Vaccinex Rochester).
Gross proceeds ~$3.7M; closing on Feb 8, 2024.
Executive officers and directors subject to 45-day lock-up on sales of common stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.